Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: DRUG: paclitaxel albumin-stabilized nanoparticle formulation|PROCEDURE: gene expression analysis|PROCEDURE: laboratory biomarker analysis|PROCEDURE: pharmacological study|PROCEDURE: polymerase chain reaction
Sponsor: Eastern Cooperative Oncology Group
Collaborators: National Cancer Institute (NCI)